Armistice Capital’s Boston Scientific BSX Stock Holding History

Armistice Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.3M	Buy	+265,201	New	+$14.4M	0.14%	101
2026 Q1	–	Sell	-114,025	Closed	-$10.9M	–	290
2025 Q4	$10.9M	Buy	114,025 +33,802	+42%	+$3.31M	0.13%	98
2025 Q3	$7.83M	Buy	80,223 +5,223	+7%	+$541K	0.12%	92
2025 Q2	$8.06M	Buy	75,000 +25,238	+51%	+$2.55M	0.14%	78
2025 Q1	$5.02M	Buy	+49,762	New	+$5.01M	0.08%	114
2024 Q4	–	Sell	-56,855	Closed	-$4.76M	–	243
2024 Q3	$4.76M	Buy	56,855 +33,555	+144%	+$2.65M	0.08%	128
2024 Q2	$1.79M	Buy	+23,300	New	+$1.71M	0.02%	149
2021 Q1	–	Sell	-500,000	Closed	-$18M	–	114
2020 Q4	$18M	Buy	+500,000	New	+$18M	0.61%	50

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Armistice Capital's BSX Position: Q2 2026 in Review

Armistice Capital opened a new position in Boston Scientific (BSX) in Q2 2026: 265,201 shares worth $11.3M. The stake represents 0.14% of the portfolio and ranks #101 among its holdings. This is a return to the name: Armistice Capital previously reported a position in BSX as recently as Q4 2025.

Armistice Capital first reported a position in BSX in Q4 2020 and has held it in 8 quarters since. The position peaked at $18M in Q4 2020. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Armistice Capital held 265,201 shares of Boston Scientific worth $11.3M as of Q2 2026.
Boston Scientific was a new Armistice Capital position in Q2 2026.
Boston Scientific made up 0.14% of Armistice Capital's portfolio in Q2 2026, its #101 holding.
Armistice Capital first reported a position in Boston Scientific in Q4 2020 and has held it in 8 quarters since.
Armistice Capital's Boston Scientific position peaked at $18M in Q4 2020.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.